世界の個別化がん治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Personalized Cancer Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12564 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、個別化がん治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。個別化がん治療の種類別市場規模（モノクローナル抗体、個別化がんワクチン、その他）、用途別市場規模（乳がん、肺がん、慢性骨髄性白血病、腸がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・個別化がん治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Merck、Novartis、Amgen、Celgene、Bayer、Roche、Astellas、Astrazeneca、Johnson & Johnson、Agilent、Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、個別化がんワクチン、その他 ・用途別分析2016年-2026年：乳がん、肺がん、慢性骨髄性白血病、腸がん、その他 ・個別化がん治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・個別化がん治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・個別化がん治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・個別化がん治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・個別化がん治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Personalized Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Personalized Cancer Medicine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Personalized Cancer Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Personalized Cancer Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Monoclonal Antibodies
Personalized Cancer Vaccines
Other

Market segment by Application, can be divided into
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer

Market segment by players, this report covers
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Personalized Cancer Medicine
1.2 Classification of Personalized Cancer Medicine by Type
1.2.1 Overview: Global Personalized Cancer Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Personalized Cancer Medicine Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Personalized Cancer Vaccines
1.2.5 Other
1.3 Global Personalized Cancer Medicine Market by Application
1.3.1 Overview: Global Personalized Cancer Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Global Personalized Cancer Medicine Market Size & Forecast
1.5 Global Personalized Cancer Medicine Market Size and Forecast by Region
1.5.1 Global Personalized Cancer Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Personalized Cancer Medicine Market Size by Region, (2016-2021)
1.5.3 North America Personalized Cancer Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Personalized Cancer Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Personalized Cancer Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Personalized Cancer Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Personalized Cancer Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Cancer Medicine Market Drivers
1.6.2 Personalized Cancer Medicine Market Restraints
1.6.3 Personalized Cancer Medicine Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Personalized Cancer Medicine Product and Solutions
2.1.4 Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Personalized Cancer Medicine Product and Solutions
2.2.4 Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Personalized Cancer Medicine Product and Solutions
2.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Personalized Cancer Medicine Product and Solutions
2.4.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Personalized Cancer Medicine Product and Solutions
2.5.4 Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Recent Developments and Future Plans
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Personalized Cancer Medicine Product and Solutions
2.6.4 Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bayer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Personalized Cancer Medicine Product and Solutions
2.7.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Roche Recent Developments and Future Plans
2.8 Astellas
2.8.1 Astellas Details
2.8.2 Astellas Major Business
2.8.3 Astellas Personalized Cancer Medicine Product and Solutions
2.8.4 Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Astellas Recent Developments and Future Plans
2.9 Astrazeneca
2.9.1 Astrazeneca Details
2.9.2 Astrazeneca Major Business
2.9.3 Astrazeneca Personalized Cancer Medicine Product and Solutions
2.9.4 Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Astrazeneca Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Personalized Cancer Medicine Product and Solutions
2.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Agilent
2.11.1 Agilent Details
2.11.2 Agilent Major Business
2.11.3 Agilent Personalized Cancer Medicine Product and Solutions
2.11.4 Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Agilent Recent Developments and Future Plans
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Personalized Cancer Medicine Product and Solutions
2.12.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Cancer Medicine Players Market Share
3.2.2 Top 10 Personalized Cancer Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Personalized Cancer Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personalized Cancer Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Personalized Cancer Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Personalized Cancer Medicine Revenue Market Share by Application (2016-2021)
5.2 Personalized Cancer Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Personalized Cancer Medicine Revenue by Type (2016-2026)
6.2 North America Personalized Cancer Medicine Revenue by Application (2016-2026)
6.3 North America Personalized Cancer Medicine Market Size by Country
6.3.1 North America Personalized Cancer Medicine Revenue by Country (2016-2026)
6.3.2 United States Personalized Cancer Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Personalized Cancer Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Personalized Cancer Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Personalized Cancer Medicine Revenue by Type (2016-2026)
7.2 Europe Personalized Cancer Medicine Revenue by Application (2016-2026)
7.3 Europe Personalized Cancer Medicine Market Size by Country
7.3.1 Europe Personalized Cancer Medicine Revenue by Country (2016-2026)
7.3.2 Germany Personalized Cancer Medicine Market Size and Forecast (2016-2026)
7.3.3 France Personalized Cancer Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Personalized Cancer Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Personalized Cancer Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personalized Cancer Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Personalized Cancer Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region
8.3.1 Asia-Pacific Personalized Cancer Medicine Revenue by Region (2016-2026)
8.3.2 China Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8.3.5 India Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Personalized Cancer Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Personalized Cancer Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Personalized Cancer Medicine Revenue by Type (2016-2026)
9.2 South America Personalized Cancer Medicine Revenue by Application (2016-2026)
9.3 South America Personalized Cancer Medicine Market Size by Country
9.3.1 South America Personalized Cancer Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Personalized Cancer Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Personalized Cancer Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personalized Cancer Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Personalized Cancer Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country
10.3.1 Middle East & Africa Personalized Cancer Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Personalized Cancer Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Personalized Cancer Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Personalized Cancer Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Personalized Cancer Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Personalized Cancer Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Personalized Cancer Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Personalized Cancer Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Personalized Cancer Medicine Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Personalized Cancer Medicine Product and Solutions
Table 9. Abbott Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Personalized Cancer Medicine Product and Solutions
Table 13. Merck Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Personalized Cancer Medicine Product and Solutions
Table 17. Novartis Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Amgen Corporate Information, Head Office, and Major Competitors
Table 19. Amgen Major Business
Table 20. Amgen Personalized Cancer Medicine Product and Solutions
Table 21. Amgen Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Major Business
Table 24. Celgene Personalized Cancer Medicine Product and Solutions
Table 25. Celgene Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bayer Corporate Information, Head Office, and Major Competitors
Table 27. Bayer Major Business
Table 28. Bayer Personalized Cancer Medicine Product and Solutions
Table 29. Bayer Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Roche Corporate Information, Head Office, and Major Competitors
Table 31. Roche Major Business
Table 32. Roche Personalized Cancer Medicine Product and Solutions
Table 33. Roche Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Astellas Corporate Information, Head Office, and Major Competitors
Table 35. Astellas Major Business
Table 36. Astellas Personalized Cancer Medicine Product and Solutions
Table 37. Astellas Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Astrazeneca Corporate Information, Head Office, and Major Competitors
Table 39. Astrazeneca Major Business
Table 40. Astrazeneca Personalized Cancer Medicine Product and Solutions
Table 41. Astrazeneca Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Personalized Cancer Medicine Product and Solutions
Table 45. Johnson & Johnson Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Agilent Corporate Information, Head Office, and Major Competitors
Table 47. Agilent Major Business
Table 48. Agilent Personalized Cancer Medicine Product and Solutions
Table 49. Agilent Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Takeda Corporate Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Personalized Cancer Medicine Product and Solutions
Table 53. Takeda Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Personalized Cancer Medicine Revenue (USD Million) by Players (2019-2021)
Table 55. Global Personalized Cancer Medicine Revenue Share by Players (2019-2021)
Table 56. Breakdown of Personalized Cancer Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Personalized Cancer Medicine Players Head Office, Products and Services Provided
Table 58. Personalized Cancer Medicine Mergers & Acquisitions in the Past Five Years
Table 59. Personalized Cancer Medicine New Entrants and Expansion Plans
Table 60. Global Personalized Cancer Medicine Revenue (USD Million) by Type (2016-2021)
Table 61. Global Personalized Cancer Medicine Revenue Share by Type (2016-2021)
Table 62. Global Personalized Cancer Medicine Revenue Forecast by Type (2021-2026)
Table 63. Global Personalized Cancer Medicine Revenue by Application (2016-2021)
Table 64. Global Personalized Cancer Medicine Revenue Forecast by Application (2021-2026)
Table 65. North America Personalized Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Personalized Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Personalized Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Personalized Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Personalized Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Personalized Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Personalized Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Personalized Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Personalized Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Personalized Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Personalized Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Personalized Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Personalized Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Personalized Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Personalized Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Personalized Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Personalized Cancer Medicine Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Personalized Cancer Medicine Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Personalized Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Personalized Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Personalized Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Personalized Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Personalized Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Personalized Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Personalized Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Personalized Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Personalized Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Personalized Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Personalized Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Personalized Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Personalized Cancer Medicine Picture
Figure 2. Global Personalized Cancer Medicine Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Personalized Cancer Vaccines
Figure 5. Other
Figure 6. Personalized Cancer Medicine Revenue Market Share by Application in 2020
Figure 7. Breast Cancer Picture
Figure 8. Lung Cancer Picture
Figure 9. Chronic Myeloid Leukaemia Picture
Figure 10. Bowel Cancer Picture
Figure 11. Other Cancer Picture
Figure 12. Global Personalized Cancer Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Personalized Cancer Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Personalized Cancer Medicine Revenue Market Share by Region (2016-2026)
Figure 15. Global Personalized Cancer Medicine Revenue Market Share by Region in 2020
Figure 16. North America Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Personalized Cancer Medicine Market Drivers
Figure 22. Personalized Cancer Medicine Market Restraints
Figure 23. Personalized Cancer Medicine Market Trends
Figure 24. Abbott Recent Developments and Future Plans
Figure 25. Merck Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Amgen Recent Developments and Future Plans
Figure 28. Celgene Recent Developments and Future Plans
Figure 29. Bayer Recent Developments and Future Plans
Figure 30. Roche Recent Developments and Future Plans
Figure 31. Astellas Recent Developments and Future Plans
Figure 32. Astrazeneca Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. Agilent Recent Developments and Future Plans
Figure 35. Takeda Recent Developments and Future Plans
Figure 36. Global Personalized Cancer Medicine Revenue Share by Players in 2020
Figure 37. Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Personalized Cancer Medicine Revenue Market Share in 2020
Figure 39. Global Top 10 Players Personalized Cancer Medicine Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Personalized Cancer Medicine Revenue Share by Type in 2020
Figure 42. Global Personalized Cancer Medicine Market Share Forecast by Type (2021-2026)
Figure 43. Global Personalized Cancer Medicine Revenue Share by Application in 2020
Figure 44. Global Personalized Cancer Medicine Market Share Forecast by Application (2021-2026)
Figure 45. North America Personalized Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 46. North America Personalized Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 47. North America Personalized Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 48. United States Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Personalized Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 52. Europe Personalized Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 53. Europe Personalized Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 54. Germany Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Personalized Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Personalized Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Region (2016-2026)
Figure 62. China Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Personalized Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 69. South America Personalized Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 70. South America Personalized Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Personalized Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

---